Maureen T. Kavanah, MD
Emeritus Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Surgery
Surgical Oncology

MD, Tufts University School of Medicine
AB, Emmanuel College



Maureen T. Kavanah, MD is Associate Professor Emeritus of surgery at BU School of Medicine (BUSM) and a surgical oncologist at Boston Medical Center (BMC), received the prestigious 2012 National Surgical Adjuvant Breast and Bowel Project (NSABP) Distinguished Investigator Lifetime Achievement Award for her extraordinary contributions and meritorious service to the NSABP in support of clinical research in breast and colorectal cancers.

During her nearly three decades of service on the Boston University Medical Campus, Dr. Kavanah has exemplified the spirit of the award through her dedication to the promotion, publication, and presentation of clinical research. “This award reflects not only Dr. Kavanah’s commitment to excellence in research and patient care, but to advancing treatment for breast cancer nationally and internationally,” says Gerard Doherty, MD, the James Utley Professor and Chair of Surgery at BUSM and chief of surgery at BMC.

Dr. Kavanah became a research investigator with the NSABP in 1981, and has since held several leadership positions within the organization. As the principal investigator of NSABP Clinical Research at BMC, she has led numerous NSABP-sponsored clinical studies in breast and bowel cancers. She has served on NSABP’s Board of Directors since 1988 and also serves as the protocol chair for the Breast Cancer Prevention Trial (P-1) and chair of the Ethics Committee.

In addition to her renowned scientific achievements, Dr. Kavanah has dedicated her time to the scientific community by serving as a faculty supervisor for many young investigators. In 1990, she established BMC as a full-member institution of the Southwest Oncology Group (SWOG) and served as its principal investigator until 1994. Dr. Kavanah belongs to numerous professional organizations and has been a member of the Board of Governors of the American College of Surgeons, president of the Massachusetts chapter of the American College of Surgeons, president of the New England Cancer Society, and chair of the National Cancer Institute Central Institutional Review Board. She lectures extensively and has been chosen as a “Top Doctor” by Boston Magazine annually since 2008.

Dr. Kavanah received the 2012 award during a ceremony held in Scottsdale, Arizona, on April 29 at the NSABP clinical trials annual meeting. The NSABP Foundation, Inc., has a 50-year history of designing and conducting clinical trials that have changed the standard of treatment for breast and colorectal cancers



NSABP Treatment Trials
10/01/2000 - 01/31/2018 (PI)
NSABP Foundation NIH

P384 Nsabp-Prevent 5/31/9 P1, P2, P3 (STAR & CO-STAR)
10/01/1999 - 05/31/2012 (PI)
NSABP Foundation NIH-NCI

P385 Nsabp-Protocol 1/31/
10/01/1996 - 02/28/2002 (PI)
NSABP Foundation

S923 Univ Of Pitt 1/31/97
02/01/2000 - 01/31/2001 (PI)
University of Pittsburgh

P351 Nasabp 83
10/01/1999 - 09/30/2000 (PI)
NSABP Foundation


Title


Yr Title Project-Sub Proj Pubs
1996 PRIMARY BREAST CANCER THERAPY GROUP NSABP 5U10CA022489-19
1995 PRIMARY BREAST CANCER THERAPY GROUP NSABP 5U10CA022489-18
1994 PRIMARY BREAST CANCER THERAPY GROUP NSABP 5U10CA022489-17
1993 PRIMARY BREAST CANCER THERAPY GROUP NSABP 5U10CA022489-16
1992 PRIMARY BREAST CANCER THERAPY GROUP - NSABP 2U10CA022489-15
1989 PRIMARY BREAST CANCER THERAPY GROUP 5U10CA022489-12
1986 PRIMARY BREAST CANCER THERAPY GROUP - NSABP 3U10CA022489-08S1
1986 PRIMARY BREAST CANCER THERAPY GROUP - NSABP 5U10CA022489-09

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kim NE, Conway-Pearson L, Kavanah M, Mendez J, Sachs TF, Drake FT, Ko NY, McAneny D, Cassidy MR. Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation. J Am Coll Surg. 2020 06; 230(6):947-955.View Related Profiles. PMID: 31809861
     
  2. Feeney T, Cassidy M, Tripodis Y, McAneny D, Kavanah M, Sachs T, Tseng JF, Drake FT. Correction to: Association of Primary Language with Outcomes After Operations Typically Performed to Treat Cancer: Analysis of a Statewide Database. Ann Surg Oncol. 2019 12; 26(Suppl 3):887-888.View Related Profiles. PMID: 31313031
     
  3. Feeney T, Cassidy M, Tripodis Y, McAneny D, Kavanah M, Sachs T, Tseng JF, Drake FT. Association of Primary Language with Outcomes After Operations Typically Performed to Treat Cancer: Analysis of a Statewide Database. Ann Surg Oncol. 2019 Sep; 26(9):2684-2693.View Related Profiles. PMID: 31187361
     
  4. Battaglia TA, Howard MB, Kavanah M, Prout MN, Chapman C, David MM, McKinney R, Kronman A, Dumont T, Freund KM. The addition of internists to a breast health program. Breast J. 2012 Jan-Feb; 18(1):58-64.View Related Profiles. PMID: 22098389; DOI: 10.1111/j.1524-4741.2011.01179.x;
     
  5. Graham K, de las Morenas A, Tripathi A, King C, Kavanah M, Mendez J, Stone M, Slama J, Miller M, Antoine G, Willers H, Sebastiani P, Rosenberg CL. Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. Br J Cancer. 2010 Apr 13; 102(8):1284-93.View Related Profiles. PMID: 20197764; PMCID: PMC2855998; DOI: 10.1038/sj.bjc.6605576;
     
  6. Emery LA, Tripathi A, King C, Kavanah M, Mendez J, Stone MD, de las Morenas A, Sebastiani P, Rosenberg CL. Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression. Am J Pathol. 2009 Sep; 175(3):1292-302.View Related Profiles. PMID: 19700746; PMCID: PMC2731147; DOI: 10.2353/ajpath.2009.090115;
     
  7. Tripathi A, King C, de la Morenas A, Perry VK, Burke B, Antoine GA, Hirsch EF, Kavanah M, Mendez J, Stone M, Gerry NP, Lenburg ME, Rosenberg CL. Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients. Int J Cancer. 2008 Apr 1; 122(7):1557-66.View Related Profiles. PMID: 18058819
     
  8. Méndez JE, Lamorte WW, de Las Morenas A, Cerda S, Pistey R, King T, Kavanah M, Hirsch E, Stone MD. Influence of breast cancer margin assessment method on the rates of positive margins and residual carcinoma. Am J Surg. 2006 Oct; 192(4):538-40.View Related Profiles. PMID: 16978970
     
  9. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 2005 Nov 16; 97(22):1652-62. PMID: 16288118
     
  10. Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg. 2002 Nov; 137(11):1253-7.View Related Profiles. PMID: 12413312
     
Showing 10 of 25 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 23 publications over 19 distinct years, with a maximum of 3 publications in 2019

YearPublications
19841
19851
19861
19881
19931
19951
19961
19982
19991
20001
20011
20022
20051
20061
20081
20091
20101
20111
20193


A Double Diagnosis – Cancer While Poor

The Boston Globe 12/29/2018
Contact for Mentoring:

75 E. Newton St Collamore Building
Boston MA 02118
Google Map

617.638.8473
Download vCard

Kavanah's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (170) concept(s)
_
Media Mentions
_
Co-Authors
See all (20) people
_
Similar People
See all (60) people
_
Same Department
Search Department